Anti-Amyloid Drugs for Alzheimer’s Face a Reckoning Over What ‘Benefit’ Really Means
A new Journal of Neurology Comment argues the Alzheimer's field has avoided honestly assessing whether licensed anti-amyloid drugs deliver clinically ...
A new Journal of Neurology Comment argues the Alzheimer's field has avoided honestly assessing whether licensed anti-amyloid drugs deliver clinically ...
A new bibliometric analysis in GeroScience maps 22 years of dual-task research in cognitive aging, tracing its evolution from gait ...
A four-cohort study of nearly 16,000 older adults found that progression in frailty raises dementia risk while recovery from pre-frailty ...
A new study in two large national cohorts finds that unfavorable social determinants of health are associated with markedly higher ...
A machine-learning speech clock developed by Trinity College Dublin researchers estimates age from voice features and links older-sounding speech to ...
A landmark study of more than 16,500 people in the United Kingdom and Australia shows that glucose-lowering medications often persist ...
A phenome-wide Mendelian randomization study of over 265,000 people suggests the CALLY index, a composite of CRP, albumin and lymphocyte ...
A systematic review and meta-analysis of 13 longitudinal studies finds that baseline cognitive function, but not age or education, predicts ...
A new letter in the Journal of Clinical Sleep Medicine argues that REM sleep without atonia in people taking antidepressants ...
A nationwide German study of nearly 100,000 patients hospitalized for peripheral arterial disease finds that dementia, unlike depression or anxiety, ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine